Law & policy

Latest content

IPBC Global ends with questions about IP in the boardroom at the top of the agenda

The final day of this year’s event in Seattle saw some of the market’s biggest names explain how to get the attention of the c-suite

17 November 2021

Four things to watch as China’s first patent linkage litigation is filed

Beijing IP Court lawsuit launched by Japan’s Chugai Pharmaceutical will be inaugural test of the new system, and possible procedural issues are already appearing

16 November 2021

Semiconductors, FRAND, diversity and danger – Day Two of IPBC Global 2021

Highlights from the plenaries, breakouts and networking sessions as the world’s premier IP business event continues in Seattle

16 November 2021

Judge rejects latest attack on PTAB discretionary denials, but other challenges loom

The fierce battle over the NHK-Fintiv rule could become a key question for the Biden Administration’s USPTO director nominee

15 November 2021

IPBC Global kicks off at a time when private equity money is pouring into the IP market

Delegates talk big ticket investments and speculate on Kathi Vidal’s USPTO Director confirmation hearing in the Senate

15 November 2021

A balanced FRAND approach is in China’s best interests

Saturday Opinion: Country must avoid pitfalls if it is to achieve its goal of wielding greater influence on global SEP issues, argues IAM China editor Bing Zhao

13 November 2021

A multi-million-dollar patent damages win for J&J in China is good news for foreign rights holders

US company’s subsidiary secures major award against a local infringer at the Supreme People’s Court

12 November 2021

MediaTek and NXP in patent clash at ITC amidst growing US chip shortage

Leading semiconductor companies both seek limited exclusion orders to halt imports at a time when supplies are tight

11 November 2021

Moderna on IP collision course with US government

The company is at loggerheads with National Institutes of Health over inventorship of crucial covid vaccine technology

11 November 2021

Dim prospects for industry 101 compromise as US Congress looks at eligibility once more

People involved in previous reform efforts say that passing any legislation will be tough as stakeholders are still years away from agreement

09 November 2021

Get unlimited access to all IAM content